HSCA Response to the U.S. Department of Commerce’s Section 232 National Security Investigation of Imports of Pharmaceuticals and Pharmaceutical Ingredients
On behalf of the Healthcare Supply Chain Association (HSCA), which represents the nation’s leading traditional healthcare...
Learn MoreHSCA Response to the U.S. Trade Representative’s Request for Comments on Unfair and Non-Reciprocal Foreign Trade Practices
On behalf of the Healthcare Supply Chain Association (HSCA), which represents the nation’s leading traditional healthcare...
Learn MoreWhat They’re Saying – Hospitals, Healthcare Organizations, and Patients Supporting the Work of GPOs to Prevent and Mitigate Drug Shortages
Recently, leading healthcare organizations, hospitals, providers, and individuals have made their voices heard on the role...
Learn MoreHSCA NAMES ANGIE BOLIVER AS PRESIDENT AND CEO
Washington, D.C. (June 10, 2024) – The Healthcare Supply Chain Association (HSCA), which represents the nation’s leading...
Learn MoreHSCA Comments on Federal Trade Commission (FTC) and Department of Health and Human Services (HHS) Joint RFI on Generic Drug Shortages
On behalf of the Healthcare Supply Chain Association (HSCA), which represents the nation’s leading traditional healthcare group...
Learn MoreHSCA Statement for the Record on the House Ways & Means Committee’s February 6, 2024 Hearing on Drug Shortages
On behalf of the Healthcare Supply Chain Association (HSCA), which represents the nation’s leading
healthcare group purchasing...
Learn More2024 HSCA Pharmacy Forum Slides
This content is password protected. To view it please enter your password below:
Password:
Learn MoreHSCA Comments to Senate Committee on Health, Labor, Education, and Pensions on Senator Cassidy’s Gene Therapy Request for Information (RFI)
On behalf of the Healthcare Supply Chain Association (HSCA), which represents the nation’s leading healthcare group purchasing...
Learn More